Career
Gerald Muench (born on March 24, 1961) is an Australian-German medical scientist Who started his career in 1995 from the University of Würzburg, Germany. He was then appointed a teaching post in the Department of Child and Adolescent Psychiatry in 1999.
In 2000, he joined the Interdisciplinary Centre for Clinical Research at the University of Leipzig, which he left in 2004 to take up a position as Senior Lecturer at James Cook University in Townsville.
In May 2008, he was appointed as Associate Professor of Pharmacology in the UWS School of Medicine, University of Western Sydney. He has worked on various projects such as of University of Western Sydney, National Health and Medical Research Council, Commonwealth Scientific and Industrial Research Organisation, J.O. & J.R. Wicking Foundation, Alzheimer"s Australia, GeroNova Research, Incorporated, Palo Alto (United States of America), Alteon Incorporated., Parsippany (United States of America), Eurochem Feinchemie, (Munich, Germany).
He belongs to family lineage of Münch
He focuses in researching various aspects of Alzheimer"s disease with a special emphasis on carbonyl stress in age-related and neurodegenerative processes, and also looking at brain inflammation as a major progression factor in Alzheimer"s disease, now widely accepted. He puts on view the role of Advanced glycation end product in Alzheimer"s Disease, which is now widely accepted fact.
He is also looking to discover and identify novel Anti-inflammatory and Neuroprotective compounds from marine macroorganisms and tropical rainforest plants, a project started through James Cook University"s "Enhancing life in the tropics".
Affiliations
He has served on the editorial boards of many international scientific journals and has been a consultant with Aventis, Roche Diagnostics, Merz, American Seed Trade Association Medica/Degussa and Geronova.
